Effects of tibolone on plasma levels of nitric oxide in postmenopausal women.
To determine the effects of tibolone on nitric oxide (NO) plasma levels in postmenopausal women. Randomized, double-blind, placebo-controlled, cross-over trial. Healthy volunteers in an academic research environment. Eighteen healthy women who have been in postmenopause for 1-4 years. Women received either tibolone 2.5 mg/day (group A) or placebo (group B) for 1 month; then the treatment was inverted for the second month. Plasma concentration of NO stable oxidation products and blood pressure were evaluated at baseline, month 1, and month 2. Baseline concentration of NO metabolites were similar in both groups. At month 1, mean concentration of NO metabolites increased significantly in group A alone. At the end of month 2, NO metabolite levels in group A returned to baseline, whereas in group B they increased significantly. Tibolone induced a sustained increase in plasma levels of NO in postmenopausal women, suggesting that tibolone may exert a direct cardiovascular protective effect in postmenopausal women.